Augstefektīvās šķidruma hromatogrāfijas metodes izstrāde un validācija purīnu un pirimidīnu noteikšanai urīna paraugos. Svetlana Silina, darba vadītājs Dr. ķīm., prof. Arturs Vīksna. Konsultanti VSIA „BKUS” Medicīniskās ģenētikas klīnikas, Ģenētiskās bioķīmijas laboratorijas ģenētiķe Zanda Daneberga, VSIA „BKUS”, Medicīniskās ģenētikas klīnikas, Ģenētiskās bioķīmijas laboratorijas vadītāja Pārsla Vēvere. Maģistra darbs. 74 lappuses, 33 attēli, 19 tabulas, 40 literatūras avoti, 27 pielikumi. Latviešu valodā. PURĪNI, PIRIMIDĪNI, PURĪNU UN PIRIMIDĪNU METABOLISMS, PURĪNU UN PIRIMIDĪNU NOZĪME ORGANISMĀ, SPEKTROFOTOMETRIJA, AEŠH, METODES VALIDĀCIJA. Darbā ir apkopota literatūra par purīniem un pirimidīniem, to nozīmi cilvēka organismā. Apskatīti ...
We describe the group selective separation and quantification of unmodified and modified purines in ...
Purine metabolism is essential for all known living creatures, including humans in whom elevated ser...
Background: Clinical presentation and disease severity in disorders of purine and pyrimidine metabol...
Objectives: To develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to quantif...
Background and aimsInborn errors of purine and pyrimidine metabolism are a diverse group of disorder...
Background and aimsInborn errors of purine and pyrimidine metabolism are a diverse group of disorder...
BACKGROUND AND AIMS:Inborn errors of purine and pyrimidine metabolism are a diverse group of disorde...
LC-MS/MS chromatograms of A: the Cal06 calibrator (16 μM) and urine specimens from B: a healthy prob...
Background: the concentration of purine and pyrimidine metabolites in urine is useful marker of defe...
Uric acid and hypoxanthine are produced in the catabolism of purine. Abnormal urinary levels of thes...
BACKGROUND Clinical presentation and disease severity in disorders of purine and pyrimidine metaboli...
SUMMARY-High-resolution liquid chromatographic pro-cedures for the separation and analysis of severa...
Purine and pyrimidine metabolism receive attention from a rapidly growing number of workers in the f...
Poremećaji metabolizma purina i pirimidina heterogena su skupina bolesti nastalih zbog smanjene ili ...
The quantification of tobacco exposure biomarkers is relevant to follow the patients' tobacco use. T...
We describe the group selective separation and quantification of unmodified and modified purines in ...
Purine metabolism is essential for all known living creatures, including humans in whom elevated ser...
Background: Clinical presentation and disease severity in disorders of purine and pyrimidine metabol...
Objectives: To develop a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to quantif...
Background and aimsInborn errors of purine and pyrimidine metabolism are a diverse group of disorder...
Background and aimsInborn errors of purine and pyrimidine metabolism are a diverse group of disorder...
BACKGROUND AND AIMS:Inborn errors of purine and pyrimidine metabolism are a diverse group of disorde...
LC-MS/MS chromatograms of A: the Cal06 calibrator (16 μM) and urine specimens from B: a healthy prob...
Background: the concentration of purine and pyrimidine metabolites in urine is useful marker of defe...
Uric acid and hypoxanthine are produced in the catabolism of purine. Abnormal urinary levels of thes...
BACKGROUND Clinical presentation and disease severity in disorders of purine and pyrimidine metaboli...
SUMMARY-High-resolution liquid chromatographic pro-cedures for the separation and analysis of severa...
Purine and pyrimidine metabolism receive attention from a rapidly growing number of workers in the f...
Poremećaji metabolizma purina i pirimidina heterogena su skupina bolesti nastalih zbog smanjene ili ...
The quantification of tobacco exposure biomarkers is relevant to follow the patients' tobacco use. T...
We describe the group selective separation and quantification of unmodified and modified purines in ...
Purine metabolism is essential for all known living creatures, including humans in whom elevated ser...
Background: Clinical presentation and disease severity in disorders of purine and pyrimidine metabol...